The positive effects of R-7050 in terms of improving poststroke hyperglycemia and glucose intolerance can likely be attributed to the inhibitory effects on TNFR/IKK and TNFR/JNK signaling. This evidence concerns the gene TNFRSF1A and Hyperglycemia.